Transforming patient lives, together
We believe that patients deserve long-lasting, transformative therapies, not just incremental improvements. We see the potential in harnessing the power of gene therapies to deliver better options for patients and believe that collaborations with other leaders in the field will get us there faster. We look for partners who share our same vision and are driven by the same urgency to deliver new gene therapies to patients. If you are interested in working with us, please contact us.
Axovant is proud to partner with the following organizations to accelerate the development of our innovative gene therapies:
Our partner for AXO-AAV-GM1 and AXO-AAV-GM2 for GM1 gangliosidosis, Tay-Sachs and Sandhoff diseases
Our partner for AXO-Lenti-PD with lentiviral vector manufacturing to support clinical development and commercialization